Cognitive Behavioral Therapy Program Aids Insomnia in Breast Cancer Survivors
By Lori Solomon HealthDay Reporter
FRIDAY, Sept. 27, 2024 -- An in-home, voice-activated cognitive behavioral therapy (CBT) program improves insomnia symptoms among breast cancer survivors, according to a study published online Sept. 24 in JAMA Network Open.
Claire M. Starling, M.P.H., from the MedStar Health Research Institute in Washington, D.C., and colleagues assessed the efficacy of a CBT-informed, voice-activated, internet-delivered program for improving insomnia symptoms among breast cancer survivors. The analysis included 70 breast cancer survivors with insomnia who were randomly assigned (1:1) to a smart speaker with a voice-interactive CBT-insomnia (CBT-I) program or educational control for six weeks.
The researchers found that from baseline to follow-up, Insomnia Severity Index scores changed by a mean of −8.4 points in the intervention group versus −2.6 in the control group. Sleep quality, as assessed by diary data, showed statistically significant improvements in the intervention group versus the control group, as did wake after sleep onset (9.54 minutes), sleep onset latency (8.32 minutes), and sleep efficiency (−0.04 percent). However, there was no improvement in total sleep time.
"Future studies should explore potential for scaling in-home sleep programs and increasing application of artificial intelligence and should compare engagement and noninferiority with other effective CBT-I programs," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
One-Week Radiotherapy for Breast Cancer Safe, Effective Up to 10 Years
TUESDAY, May 27, 2025 -- A five-fraction, one-week schedule of adjuvant breast radiotherapy is as safe and effective as a standard three-week schedule for patients with invasive...
Artificial Intelligence Flags Interval Breast Cancers Visible at Screening
FRIDAY, May 23, 2025 -- Artificial intelligence (AI) more often flags and accurately localizes interval breast cancers (IBCs) that are visible at screening than true interval or...
Trend Toward Survival Benefit Seen for REM-Inhibition in ALS
THURSDAY, May 22, 2025 -- For patients with amyotrophic lateral sclerosis (ALS), rapid eye movement (REM) inhibition via receipt of antidepressant medication is associated with a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.